These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3359738)

  • 1. Intravenous phenytoin loading in patients after neurosurgery and in status epilepticus. A population pharmacokinetic study.
    Vozeh S; Uematsu T; Aarons L; Maitre P; Landolt H; Gratzl O
    Clin Pharmacokinet; 1988 Feb; 14(2):122-8. PubMed ID: 3359738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems with phenytoin administration in neurology/neurosurgery ITU patients receiving enteral feeding.
    Kitchen D; Smith D
    Seizure; 2001 Jun; 10(4):265-8. PubMed ID: 11466022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of intravenous phenytoin in children.
    Koren G; Brand N; Halkin H; Dany S; Shahar E; Barzilay Z
    Pediatr Pharmacol (New York); 1984; 4(1):31-8. PubMed ID: 6739185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin dosing and serum concentrations in paediatric patients requiring 20 mg/kg intravenous loading.
    Piper JD; Hawcutt DB; Verghese GK; Spinty S; Newland P; Appleton R
    Arch Dis Child; 2014 Jun; 99(6):585-6. PubMed ID: 24431415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status epilepticus. The role of intravenous phenytoin.
    Cloyd JC; Gumnit RJ; McLain LW
    JAMA; 1980 Sep; 244(13):1479-81. PubMed ID: 7420642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective dose schedule for phenytoin treatment of status epilepticus in infancy and childhood.
    Albani M
    Neuropadiatrie; 1977 Aug; 8(3):286-92. PubMed ID: 578299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a phenytoin loading dose program in the emergency department.
    Brancaccio A; Giuliano C; McNorton K; Delgado G
    Am J Health Syst Pharm; 2014 Nov; 71(21):1862-9. PubMed ID: 25320136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of intravenous phenytoin in treatment of partial status epilepticus (author's transl)].
    Chauplannaz G; Mauguière F; Courjon J; Ferry S
    Nouv Presse Med; 1981 Mar; 10(13):1043-6. PubMed ID: 6784103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of intravenous loading dose of phenytoin treatment in Srinagarind Hospital.
    Tiamkao S; Chitravas N; Jitpimolmard S; Sawanyawisuth K
    J Med Assoc Thai; 2005 Nov; 88(11):1638-41. PubMed ID: 16471113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of maintenance phenytoin therapy after intravenous loading dose.
    Riviello JJ; Roe EJ; Sapin JI; Grover WD
    Pediatr Neurol; 1991; 7(4):262-5. PubMed ID: 1930417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravenous phenytoin in the treatment of status epilepticus: kinetics of central nervous system penetration.
    Wilder BJ; Ramsay RE; Willmore LJ; Feussner GF; Perchalski RJ; Shumate JB
    Ann Neurol; 1977 Jun; 1(6):511-8. PubMed ID: 883764
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of individualized phenytoin sodium loading doses administered by intravenous infusion.
    Dela Cruz FG; Kanter MZ; Fischer JH; Leikin JB
    Clin Pharm; 1988 Mar; 7(3):219-24. PubMed ID: 3356118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin monitoring in status epilepticus in infants and children.
    Richard MO; Chiron C; d'Athis P; Rey E; Aubourg P; Dulac O; Olive G
    Epilepsia; 1993; 34(1):144-50. PubMed ID: 8422847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of intravenous valproate and phenytoin in status epilepticus.
    Agarwal P; Kumar N; Chandra R; Gupta G; Antony AR; Garg N
    Seizure; 2007 Sep; 16(6):527-32. PubMed ID: 17616473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous phenytoin in acute treatment of seizures.
    Cranford RE; Leppik IE; Patrick B; Anderson CB; Kostick B
    Neurology; 1979 Nov; 29(11):1474-9. PubMed ID: 574200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly.
    Guk J; Lee SG; Chae D; Kim JH; Park K
    J Pharm Sci; 2019 Aug; 108(8):2765-2773. PubMed ID: 30940470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage.
    Kim DW; Kim TE; Ji M; Chun YI
    Clin Neuropharmacol; 2015; 38(6):248-51. PubMed ID: 26536021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.